Guggenheim Capital’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.31M Buy
36,420
+511
+1% +$18.4K 0.01% 792
2025
Q1
$1.42M Sell
35,909
-5,552
-13% -$219K 0.01% 756
2024
Q4
$1.25M Sell
41,461
-14,905
-26% -$449K 0.01% 817
2024
Q3
$1.32M Sell
56,366
-1,776
-3% -$41.5K 0.01% 974
2024
Q2
$1.03M Sell
58,142
-3,052
-5% -$54.3K 0.01% 1098
2024
Q1
$931K Buy
61,194
+2,447
+4% +$37.2K 0.01% 1217
2023
Q4
$1M Sell
58,747
-19,805
-25% -$338K 0.01% 1160
2023
Q3
$657K Buy
78,552
+30,369
+63% +$254K 0.01% 1297
2023
Q2
$1.2M Sell
48,183
-21,403
-31% -$532K 0.01% 1074
2023
Q1
$1.05M Buy
+69,586
New +$1.05M 0.01% 1156
2022
Q2
Sell
-111,655
Closed -$1.06M 2128
2022
Q1
$1.06M Buy
111,655
+24,076
+27% +$229K 0.01% 1332
2021
Q4
$1.66M Buy
87,579
+23,336
+36% +$443K 0.01% 1149
2021
Q3
$2.14M Buy
64,243
+6,623
+11% +$220K 0.01% 1020
2021
Q2
$2.24M Buy
57,620
+5,584
+11% +$217K 0.01% 1033
2021
Q1
$2.51M Buy
+52,036
New +$2.51M 0.02% 915
2018
Q2
Sell
-74,974
Closed -$1.06M 2582
2018
Q1
$1.06M Sell
74,974
-76,413
-50% -$1.08M ﹤0.01% 2046
2017
Q4
$1.24M Buy
151,387
+49,452
+49% +$405K ﹤0.01% 1970
2017
Q3
$1.21M Buy
101,935
+212
+0.2% +$2.51K ﹤0.01% 1990
2017
Q2
$1.02M Sell
101,723
-10,200
-9% -$102K ﹤0.01% 2076
2017
Q1
$1.3M Sell
111,923
-156,062
-58% -$1.82M ﹤0.01% 1950
2016
Q4
$1.25M Buy
267,985
+108,106
+68% +$503K ﹤0.01% 2019
2016
Q3
$1.24M Sell
159,879
-4,334
-3% -$33.6K ﹤0.01% 1959
2016
Q2
$995K Buy
164,213
+44,192
+37% +$268K ﹤0.01% 2062
2016
Q1
$1.02M Buy
120,021
+5,097
+4% +$43.4K ﹤0.01% 2037
2015
Q4
$1.37M Sell
114,924
-3,430
-3% -$40.9K ﹤0.01% 1903
2015
Q3
$1.19M Buy
+118,354
New +$1.19M ﹤0.01% 1980